EMCDDA Home
  • EN
Search

Table TDI-105. All clients entering inpatient treatment by primary drug and age, 2011 or most recent year available

Part (i) All opioid inpatient clients by country and age

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium096814414412595646490649
Bulgaria055914296222332923352
Czech Republic01456112167732094510451
Denmark014114610743043
Germany027284674663426346336275602756
Estonia:::::::::::
Ireland10281251561478530265970597
Greece01412935949420710064136701367
Spain:::::::::::
France1555101616455263680368
Italy:::::::::::
Cyprus001125252110395095
Latvia:::::::::::
Lithuania:::::::::::
Luxembourg::101821266::::
Hungary00481881342042
Malta:::::::::::
Netherlands011618315142742330233
Austria0532632951739341469640964
Poland2:826342783::::
Portugal:::::::::::
Romania0316282484487087
Slovenia:::::::::::
Slovakia082234453512131690169
Finland095711979392063290329
Sweden10341682021478654987890789
United Kingdom3116146494760781531351308003080
Croatia:61969776437::::
Turkey01544573902361186964148801488
Norway07114184201238204335128301283
Total2402210936173640258416921532151192315142
 

Notes:

: Indicates no data are available.

(1) Data are from 2010.

(2) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data. Heroin includes both heroin and so called 'kompot' (heroin gained from the poppy straws).

(3) Data are from 1st of April 2010 to 31st March 2011.

See also Table TDI-10 part(vii), part(viii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Inpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013